Kwick Forensic Solutions IPO Day 4: GMP ₹63

Alright folks, it’s Day 4 of the Kwick Forensic Solutions SME IPO on the BSE, and things are heating up – or perhaps, still simmering. The subscription window, which opened on August 27th and will close on August 31st, is nearing its end. Today marks a crucial point where investors typically make their final decisions. Let’s dive into the latest numbers and see what they tell us about the market’s appetite for this forensic solutions provider.

Subscription Status

As of Day 4, the subscription numbers for Kwick Forensic Solutions are, to put it mildly, non-existent. We’re seeing 0x across the board – Retail, NII (High Net-Worth Individuals), and QIB (Qualified Institutional Buyers). This is quite an unusual situation, especially this late in the IPO period. Typically, by Day 4, we’d expect to see at least some traction, even if it’s just a fraction of the total issue being subscribed. The absence of any bids from any category is definitely something to ponder. It could mean a few things: perhaps investors are waiting for the very last day to gauge the final sentiment, or it might indicate a lack of immediate interest, which could concern potential applicants. The lot size is 1600 shares, and with an issue price of ₹90 per share, the total IPO size will give us a clearer picture of the scale once subscriptions start pouring in.

GMP Update

Now, let’s talk Grey Market Premium (GMP). The current GMP for Kwick Forensic Solutions stands firm at ₹63. This is the same as yesterday’s figure, so there hasn’t been any movement. A GMP of ₹63 on an issue price of ₹90 translates to an expected listing price of around ₹153 (₹90 + ₹63). This is a healthy premium, suggesting that the market, or at least the grey market participants, are anticipating a positive debut. The fact that the GMP has remained stable, despite the zero subscription numbers, is interesting. It suggests that the underlying sentiment for the company remains positive, even if the actual subscriptions haven’t kicked off yet. This could be encouraging for those looking to apply, as it indicates a potential for listing gains, irrespective of the current subscription lull.

Should You Apply?

This is where it gets tricky. On one hand, you have a stable and attractive GMP that points towards a potential listing gain of over 70% (₹63 premium on ₹90 issue price). This is certainly a compelling factor. The expected listing price of ₹153 is quite attractive. However, the complete lack of subscription data on Day 4 is a significant red flag. It’s unusual and could signal a lack of broad market interest or perhaps a strategic wait-and-watch approach from many investors. SEBI advisors often caution about applying in IPOs with very low subscription numbers, especially in the SME segment where liquidity can sometimes be a concern. The bottom line is, while the GMP is a strong positive indicator, the subscription silence is a puzzle. If you’re a risk-taker who believes in the company’s fundamentals and is comfortable with the potential for volatile trading in SME stocks, the GMP might be enough to entice you. But for those who prefer to see concrete subscription interest before committing capital, it might be wise to wait until the final day or even consider skipping this one. Always do your own research and consult with a registered financial advisor before making any investment decisions.

View Full Kwick Forensic Solutions IPO Details